HIGHLIGHTS
- who: Bothamai Dechates and colleagues from the Department of Medicine, Chulabhorn Hospital, Chulabhorn Royal Academy, Thung Song Hong, Lak Si, Bangkok, Thailand have published the Article: Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers, in the Journal: Vaccines 2022, 10, x FOR PEER REVIEW of 31/08/2020
- what: The majority of the patients with diabetes in the study had well-controlled blood glucose levels, with 60% of them having an HbA1c level of less than or equal to 7%. The results of the subgroup analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.